Ethyl 3-bromo-4-methyl-1H-pyrazole-5-carboxylate, 95.0%, 1g

7-Bromoquinolin-4-ol, 95.0%, 100g

Hybridisation vial Non-coated, Height, 100 mm, 35 mm, 1 Piece

benzene-1,3-dicarbonyl dichloride, 99.0%, 25g

1-[[2-bromo-5-(trifluoromethyl)phenyl]methyl]-piperidine, 95+%, 1g

2,7-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9,9-didecylfluorene>98.0%(HPLC)1g

6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline, 98%, 1g

Methyl 2-(4,6-dichloropyrimidin-5-yl)acetate, 95.0%, 1g

METHYL 2-IODO-5-(TRIFLUOROMETHYL)BENZOATE, 95%, 1g

7-Bromo-2-chloroquinazoline, 95.0%, 1g

4-Nitrobenzyl bromide, min 99%, for synthesis, 100 g, glass packaging

3-BROMO-5-METHYL-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 1g

N1,N2-Dimethoxy-N1,N2-dimethyloxalamide, 95.0%, 250mg